AprilBio Co.
Latest round
- Series C
Last raised
- Aug 2021
Total raised
- $49M
Investors
- 16
About AprilBio Co.
,Ltd. focuses on developing innovative therapeutics through its proprietary SAFA™ platform, targeting autoimmune diseases and cancer with enhanced efficacy.,Ltd. was founded in 2013 in Chuncheon, South Korea. The company specializes in the development of antibody fragment-based drugs.29 million shares at KRW 16,000 each, below the expected KRW 20,000-23,000 range.7 billion.AprilBio specializes in the development of innovative therapeutics utilizing its proprietary SAFA™ platform, which incorporates an anti-serum albumin Fab associated technology. Their core offerings include antibody fragment-based drugs aimed at treating autoimmune diseases and cancer, focusing on enhancing efficacy while minimizing side effects. By leveraging its unique technology, the company seeks to improve the pharmacokinetics of its therapies. The primary customers for AprilBio's products are healthcare providers and pharmaceutical companies in the immunology and oncology fields, targeting global markets, including the United States and Europe.7. The company’s revenue model is centered around partnerships and licensing agreements with pharmaceutical companies and research institutions, focusing on the commercialization of its proprietary drug candidates. The company is focused on launching new therapeutic candidates, with specific timelines for upcoming releases as they progress through clinical trials. Additionally, AprilBio aims to expand into new geographic regions, specifically targeting markets in North America and Europe by 2025, enhancing its global footprint.
Who invested in AprilBio Co.
16 investors across 5 rounds
See all investors in AprilBio Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AprilBio Co.
Who invested in AprilBio Co.?
AprilBio Co. has 16 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AprilBio Co. raised?
AprilBio Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did AprilBio Co. last raise money?
AprilBio Co.'s most recent round on record is a Series C, in Aug 2021.
What does AprilBio Co. do?
AprilBio Co. is a biotechnology company.
Where is AprilBio Co. headquartered?
AprilBio Co. is headquartered in Chuncheon, South Korea.
Which VCs invest in companies like AprilBio Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at AprilBio Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like AprilBio Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.